1. Water EA, Bowden RA. Infection in the bone
marrow transplant recipient. Infect Dis Clin
North Am 1995; 9: 823-847.
2. Yücel A. Tıp mikolojisinin dünü bugünü. I.
Ulusal Mantar Hastalıkları ve Klinik Mikoloji
Kongresi (4-6 Mayıs 1999, İzmir), Tutanaklar.
Türk Mikrobiyoloji Cem Y, 1999; 36: 3-16.
3. Richardson MD, Warnock DW. Fungal Infection.
Diagnosis and Management. 2nd ed. London:
Blackwell Science; 1997.
4. Collier L, Balows A, Sussman M (Eds). Topley
and Wilson’s Microbiology and Microbial Infections.
v.4 Ajello L, Hay RJ (v. Eds). Medical
Mycology. 9th edition. London: 2000.
5. Cassone A. Cell-mediated immunity mechanism
in fungal infections. In: Jacobs PH, Nall L
(eds). Fungal Disease. Biology, Immunology
and Diagnosis. New York: Marcel Dekker;
1997; 113-136.
6. Kwon Chung KJ, Bennett JE. Medical Mycology.
Philadelphia; Lea and Febiger, 1992.
7. Pfaller MA. Editorial response: The epidemiology
of invazive mycoses-Narrowing the gap.
Clin Infect Dis 1998; 27: 1148-1150.
8. Musial CE, Cockerill FR, Roberts GD. Fungal
infections of the immunocompromised host:
Clinical and laboratory aspects. Clin Microbiol
Rev 1998; 1: 349-364.
9. Varthalitis I, Meunier F. Prophylaxis of fungal
infections. Bailliére’s Clinical Infectious Diseases’de.
Ed. F.Meunier. London: Bailiére Tindall
1995: 157-177.
10. Martinez M, Lee AS, Hellinger WC, Kaplan J.
Vertebral Aspergillus osteomyelitis and acute
diskitis in patients with chronic abstructive
pulmonary disease. Mayo Clin Proc 1999; 74:
579-583.
11. Richardson MD, Kokki MH. Diagnosis and prevention
of fungal infection in the immunocompromised
patient. Blood Reviews 1998; 12: 241-
254.
12. Viscoli C, Girmenia C, Marinus A, Collette L,
Martino P, Vandercam BC, Lebeau B, Spence
D, Kremery V, De Pauw B, Meunier F. Candidemia
in cancer patients: a prospective, multicenter
surveillance study by the Invazive
Fungal Infection Group (IFI) of the European
Organization for Research and Treatment of
Candidemia (EORTC). Clin Infect Dis 1999; 28:
1071-1079.
13. Verghese S, Padmaja P, Sudha P, Sorna E,
Johni D, Vasu S. Cental venous cathether related
infections. J Commun Dis 1999; 31: 1-4.
14. Chiou CC, Groll AH, Walsh TJ. New drugs and
novel targets for treatment for invazive fungal
infections in patients with cancer. Oncologist
2000; 5: 120-135.
15. Abi-Said D, Anaissie E, Uzun Ö, Raad I,
Pinzcowski H, Vartivarian S. The epidemiology
of hematogenous candidiasis caused by different
Candida species. Clin Infect Dis 1997; 24:
11222-1128.
16. Wingard JR. Importance of Candida species
other than C.albicans as pathogens in oncology
patients. Clin Infect Dis 1995; 20: 115-125.
17. Groll AH, Kurz M, Schneider W, Witt V,
Schmidt H, Schneider M,Schwabe D. Five-yearsurvey
of invazive aspergillosis in a pediatric
cancer centre. Epidemiology, management and
long-term survival. Mycoses 1999; 42: 431-442.
18. McCullers JA, Vargas SL, Flynn PM, Razzouk
BI, Shenep JL. Candidal meningitis in children
with canser. Clin Infect Dis 2000; 31: 451-457.
19. Viscoli C, Castagnola E, Giacchino M, Cesaro
S, Properzi E, Tucci F, Alvisi P, Zanazzo G,
Surico G, Bonetti F, De Sio L, Izzi G, Di Catalo
A, ZiinoO, Massalo F, Nardi M, Santoro N,
Binda S. Bloodstream infections in children
with cancer: a multicenter surveillance study of
the Italian Association of Pediatric Haematology
and Oncology. Supportive Therapy Group-
Infectious Disease Section. Eur J Cancer 1999;
35: 770-774.
20. Ehninger G, Schuler U. Fungal infections in
haematology/oncology: are new drugs affecting
strategies of prophylaxis and treatment. Abstracts
of 5th Congress of the European Confederation
of Medical Mycology (3-6 June 1999,
Dresden, Germany). Mycoses 1999; 42: 131-
132.
21. Gözdaşoğlu S, Ertem M, Büyükkeçeci Z, Yavuzdemir
Ş, Bengisun S, Özenci H, Taçyıldız N,
Ünal E, Yavuz G, Deda G, Aysev D. Fungal
colonization and infection in children with
acute leukemia and lymphoma during induction
therapy. Med Ped Oncology 1999; 32: 344-
348.
22. Abbasi S, Shenep JL, Hughes WT. Aspergillosis
in children with cancer: A 34-year experience.
Clin Infect Dis 1999; 29: 1210-1219.
23. Hospenthal OR, Kwon-Chung KJ, Bennett JE.
Concentrations of airborne Aspergillus compared
to the incidence of invazive aspergillosis:
lack of correlation. Med Mycol 1998; 165-168.
24. Verschraegen CF, van Besien KW, Diagnani C,
Hester JP, Andersson BS, Anaissie E. Invazive
Aspergillus sinusitis during bone marrow
transplantation. Scand J Infect Dis 1997; 29:
436-438.
25. Thio CL, Smith D, Merz WG, Streifel AJ, Bova
G, Gay L, Miller CB, Per TM. Refinement of
environmental assessment during an outbreak
investigation of invazive aspergillosis in a leukemia
and bone marrow transplant unit. Infect
Control Hosp Epidemiol 2000; 21: 18-23.
26. Kremery V Jr, Mrazova M, Kunova A, Grey E,
Mardiak J, Jurga L, Sabo A, Sufliarsky J,
Sevcikova L, Sorkovska D, West D, Trupl J,
Novotny J, Mateicka F. Nosocomial candidemias
due to species other than Candida albicans
in cancer patients. Aetiology, risk factors,
and outcome of 45 episodes within 10 years in a
single cancer institution. Support Care Cancer
1999; 7: 428-431.
27. Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins
BA, Stephens DS, Baughman WS, Reingold
LA, Rothrock GA, Pfaller MA, Pinner RW,
Hajjeh RA. The epidemiology of epidemiology of
candidemia in two United States cities: results
of a population-based active surveillance. Clin
Infect Dis 1999; 29: 1164-1170.
28. Grudeva-Popova J, Goranov S. Mucocutaneous
infections in hematological malignancies. Folia
Med 1999; 41: 40-44.
29. Kennedy WA, Laurier C, Gautrin D, Ghezzo H,
Pare M, Malo JL, Contandriopoulos AP. Occurrence
and risk factors of oral candidiasis
treated with oral antifungals in seniors using
inhalled steroids. J Clin Epidemiol 2000; 53:
696-701.
30. Land G, McCracken AW. Fungal Infections in
the Compromised Host. Handbook of Applied
Mycology’de. Eds. Arora DK, Ajello L, Mukerji
KG. NewYork; Marcel Dekker, Inc. 1991: 75-
115.
31. Pfaller MA. Epidemiology and control of fungal
infections. Clin Infect Dis 1994; 19: 8-13.
32. Jabra-Rizk MA, Baqui aama, Kelley JI, Falkler
WA, Merz WG, Meiller TF. Identification of
Candida dubliniensis in a prospective study in
the United States. J Clin Microbiol 1999; 37:
321-326.
33. Muller FM, Groll AH, Walsh TJ. Current approaches
to diagnosis and treatment of fungal
infections in children infected with human immuno
deficiency virus. Eur J Pediatr 1999; 58:
187-1999.
34. Nunez M, Peacock JE Jr, Chin R Jr. Pulmonary
cryptococcosis in the immunocompetent
host. Therapy with oral fluconazole: a report of
four cases and a review of the literature. Chest
2000; 118: 527-534.
35. Agrawal A, Brown WS, McKenzie S. Cryptococcal
arthritis in an immunocompetent host. JSC
Med Assoc 2000; 96: 297-299.
36. Prendiville S, Bielamowicz SA, Hawrych A,
Deeb ZE. Isolated cryptococcal sphenoid sinusitis
with septicemia, meningitis, and subsequent
skull base osteomyelitis in an immunocompetent
patient. Otolaryngol Head Neck Surg
2000; 123: 277-279.
37. Patel P, Ramanathan J, Kayser M, Baran J Jr.
Primary cutaneous cryptococcosis of the nose in
an immunocompetent woman. J Am Acad Dermatol
2000; 43: 344-345.
38. Fernandes O de F, Costa TR, Costa MR, Soares
AJ, Pereira AJ, Silva MR. Cryptococcus neoformans
isolated from patients with AIDS. Rev
Soc Bras Med Trop 2000; 33: 75-78.
39. Yücel A. Kriptokok ve diğer maya formundaki
mantarlar. İnfeksiyon Hastalıkları’nda. 2nci
Baskı. Ed. Wilke A, Söyletir G, Doğanay M.
2001 (Baskıda).
40. Chen S, Sorrel T, Nimmo G, Speed B, Currie B,
Ellis D, Marriot D, Pfeiffer T, Parr D, Byth K.
Epidemiology and host- and variety- dependent
characteristics of infection due to Cryptococcus
neoformans in Australia and New Zealand.
Clin Infect Dis 2000; 31: 499-508.
41. Graybill JR. Prevention of systemic mycoses in
patients who are not neutropenic: should We
Do It? Can We Do It? Braz J Infect Dis 2000; 4:
108-112.
42. Singh N. Antifungal prophylaxis for solid organ
transplant recipients: Seeking clarity amidst
controversry. Clin Infect Dis 2000; 31: 345-353.
43. Rabkin JM, Oroloff SL, Corless CL, Benner
KG, Flora KD, Rosen HR, Olyaei AJ. Association
of fungal infection and increased mortality
in liver transplant recipients. Am J Surg 2000;
179: 426-430.
44. Dunn DL, Simmons RL. Opportunistic Infections
After Renal Transplant. Infections in Surgery.
Preventing Complications in Practice’de.
New York 1990: 5-8.
45. Jost L, Jost L, Nogues M, Davalos M, Turin M,
Manes F, Leiguarda R). Neurological complications
of renal transplant. Medicina 2000; 60:
161-164.
46. Huang JW, Huang KY, Wu KD, Peng YS, Tsai
TJ, Hsieh BS. Clinical features of and risk factors
for fungal peritonitis in peritoneal dialysis
patients. J Formos Med Assoc 2000; 99: 544-
548.
47. Chadeganipour M, Shadzi S, Dehghan P, Bijary
J. The incidence of opportunistic fungi in patients
suspected of tuberculosis. Mycosis 2000;
43: 269-272.
48. Franquet T, Muller NL, Gimenez A, Domingo
P, Plaza V, Bordes R. Semiinvazive pulmonary
aspergillosis in chronic obstructive pulmonary
disease: radiologic and pathologic findings in
nine patients. AJR Am J Rontgenol 2000; 174:
51-56.
49. Capone D, Wanke B, Monteiro PC, Lazera MS,
de Noronha AG, Valle AC, Moreno AM,
Londero AT. Chronic pulmonary histoplasmosis
in the state of Rio de Janeiro, Brazil. 1999; 145:
75-79.
50. Saubolle MA. Fungal pneumonias. Semin Respir
Infect 2000; 15: 162-177.
51. Yamazaki T, Kume H, Murase S, Yamashita E,
Arisa M. Epidemiology of visceral mycoses:
Analysis of data in Annual of the Pathological
Autopsy cases in Japan. J Clin Microbiol 1999;
37: 1732-1738.
52. Imwidthaya P. Systemic fungal infections in
Thailand. J Med Vet Mycol 1994; 32: 395-399.
53. Guiot HFL, Fibbe WE, van’t Wout JW. Risk
factors for fungal infection in patients with malignant
hematologic disorders: Implications for
empirical therapy and prophylaxis. Clin Infect
Dis 1994; 18: 525-532.
54. Karthaus M, Doellmann T, Klimasch T, Elser
C, Rosenthal C, Ganser A, Heil G. Intensive
intravenous amphotericin B for prophylaxis of
systemic fungal infections. Results of a prospective
controlled pilot study in acute leukemia
patients. Chemotherapy 2000; 46: 293-302.
55. Schwartz S, Behre G, Heinemann V, Wandt H,
Schilling E, Arning M, Trittin A, Kern WV,
Boenisch O, Bosse D, Lenz K, Ludwig WD, Hiddemann
W, Siegert W, Beyer J. Aerosolized
amphotericin B inhalations as prophylaxis of
invazive aspergillus infections during prolonged
neutropenia: results of a prospevtive
randomized multicenter trial. Blood 1999; 93:
3654-3661.
56. Walsh TJ, Seibel NL, Arndt C, Harris RE, Dinubile
MJ, Reboli A, Hiemo J, Chanock SJ.
Amphotericin B lipid complex in pediatric patients
with invazive fungal infections. Pediatr
Infect Dis J 1999; 18: 702-708.
57. Lortholary O, Dupont B. Antifungal prophylaxis
during neutropenia and immunodeficiency.
Clin Microbiol Rev 1997; 10: 477-504.
58. Kern W, Behre G, Rudolf T, Kerkhoff A, Grote-
Metke A, Eimermacher I, Kubica U, Wormann
B, Buchner T, Hiddemann W. Failure of fluconazole
prophylaxis to reduce mortality or the
requirement of systemic amphotericin B therapy
during treatment for refractory acute myeloid
leukemia.: results of a prospective randomized
phase III study. German AML Cooperative
Group. Cancer 1998; 83: 291-301.
59. Bohme A, Karthaus M, Hoelzer D. Antifungal
prophylaxis in neutropenic patients with hematologic
malignancies: is there a real benefit?
Chemotherapy 1999; 45: 224-232.
60. Barnes RA. Working Party of the British Society
for Antimicrobial Chemotherapy Report.
Therapy of deep fungal infection in haematological
malignancy. J.Antimicrob Chemother
1997; 40: 779-788.
61. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas
PG, Dismukes WE, Edwards JE. Practise
guideliness for the treatment of candidiasis.
Clin Infect Dis 2000; 30: 662-678.
62. National Committee for Laboratory Standards.
Reference Method for Broth Dilution Antifungal
Susceptibility Testing for Yeasts; Proposed
Standard. Document M27-P. National Committee
for Laboratory Standards.Villanova, 1992.
63. National Committee for Laboratory Reference
Method for Broth Dilution Antifungal Susceptibility
Testing for Yeasts;. Tentative Standard.
Document M27-T National Committee for
Laboratory Standards. Villanova, 1995.
64. National Committee for Laboratory Reference
Method for Broth Dilution Antifungal Susceptibility
Testing for Yeasts. Approved Standard;
Document M27-A National Committee for
Laboratory Standards.Villanova, 1997.
65. National Committee for Laboratory Standards.
Reference Method for Broth Dilution Antifungal
Susceptibility Testing of Conidium-Forming
Filamentous Fungi; Proposed Standard. Document
M38-P. National Committee for Laboratory
Standards. Wayne, 1998.
66. Espinel-Ingroff A, Barchiesi F, Hazen KC,
Martinez-Suarez V, Scalise G. Standardization
of antifungal susceptibility testing and clinical
relevance. Med Mycol 1998; 36: 68-78.
67. Espinel-Ingroff A. Clinical utility of in vitro antifungal
susceptibility testing. Rev Esp Quimioter
2000; 13: 161-166.
68. Ghannoum M. Susceptibility testing of fungi:
Current status of correlation of in vitro data
with clinical outcome. J Clin Microbiol 1996;
34: 489-495.
69. Yücel A. Mikozların tedavisi: Antifungal ilaçlar.
Yücel A, Tabak F, Öztürk R, Mert A. (ed).
Günümüzde Antimikrobik Tedavi’de. İstanbul
Bulaşıcı Hastalıklarla Savaş Derneği Yayın no:
12. İstanbul, 1998: 117-142.
70. Del Favero A. Management of fungal infections
in neutropenic patients: more doubts than certainties?
Int J Antimicrob Agents 2000; 16:
135-137.
71. Aşcıoğlu S, de Pauw BE, Meis JFMG. Prophylaxis
and treatment of fungal infections associated
with haematological malignancies. Int J
Antimicrob Agents 2000; 15: 159-168.
72. Herbrecht R, Neuville S, Letscher-Bru V, Natarajan-
Ame S, Lortholary O. Fungal infections
in patients with neutropenia: challenges in prophylaxis
and treatment. Drugs Aging 2000; 17:
339-351.
73. Andriole TV. Current and future antifungal
therapy: new targets for antifungal therapy.
Int J Antimicrob Agents 2000; 16: 317-321.
74. Bastert J, Schaller M, Korting HC, Evans EGV.
Current and future approaches to antimycotic
treatment in the era of resistant fungi and immunocompromised
hosts. Int J Antimicrob
Agents 2001; 17: 81-91.
Thank you for copying data from http://www.arastirmax.com
